VVN 481
Alternative Names: VVN-481Latest Information Update: 24 Mar 2024
At a glance
- Originator VivaVision Biotech
- Class Eye disorder therapies; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Retinal disorders